Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

 

Association between vitamin D and COVID-19 infection and mortality in Taiwanese patients

Sheng et al., Journal of the Chinese Medical Association, doi:10.1097/JCMA.0000000000001294, Sep 2025
https://c19early.org/sheng2.html
Mortality 91% Improvement Relative Risk Vitamin D for COVID-19  Sheng et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 67 patients in Taiwan Lower mortality with higher vitamin D levels (p=0.035) c19early.org Sheng et al., J. the Chinese Medical A.., Sep 2025 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 126 studies, recognized in 18 countries.
No treatment is 100% effective. Protocols combine treatments.
6,100+ studies for 180 treatments. c19early.org
Retrospective 481 symptomatic adults in Taiwan showing higher mortality among COVID-19-positive patients with vitamin D deficiency. There was no crude association between vitamin D level and infection risk, however infection was analyzed univariately using vitamin D as a continuous variable only. Multivariable analysis was only done for mortality.
This is the 223rd COVID-19 sufficiency study for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 328,817,133,764,008,192 vigintillion).
risk of death, 90.6% lower, OR 0.09, p = 0.04, high D levels (≥30 ng/mL) 22, low D levels (<20 ng/mL) 45, adjusted per study, inverted to make OR<1 favor high D levels (≥30 ng/mL), multivariable, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Sheng et al., 12 Sep 2025, retrospective, Taiwan, peer-reviewed, mean age 58.2, 6 authors. Contact: shchiu2@vghtpe.gov.tw, hyhuang21@vghtpe.gov.tw.
Abstract: Journal of the Chinese Medical Association Publish Ahead of Print DOI: 10.1097/JCMA.0000000000001294 Association between vitamin D and COVID-19 infection and mortality in ED Taiwanese patients Ching-Ching Shenga,b, Shuan-Yi Sua, Ying Lianga, Hui-Chuan Chenga, Hsin-Yi Huangc,*, Hsiao-Hui Chiua,d,e,* Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC b Department of Nursing, Chang Jung Christian University, Tainan, Taiwan, ROC EP T a c Department of Information Management, Taipei Veterans General Hospital, Taipei, Taiwan, ROC d Department of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan, ROC e School of Nursing, National Defense Medical Center, Taipei, Taiwan, ROC C Received date: September 24, 2024. Accepted date: August 22, 2025. Author contributions: Rn Ching-Ching Sheng and Rn Shuan-Yi Su contributed equally to this A C manuscript. Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article. *Address correspondence. Rn. Hsiao-Hui Chiu, Department of Nursing, Taipei Veterans General Hospital, 201, Section 2, Shi-Pai Road, Taipei 112 ,Taiwan, ROC. Tel: +886-2871-12121 ext. 82398 Fax: +886-2875-7664 E-mail: shchiu2@vghtpe.gov.tw 1 Ms. Hsin-Yi Huang, Department of Information Management, Taipei Veterans General Hospital, 201, Section 2, Shi-Pai Road, Taipei 112, Taiwan, ROC. E-mail: hyhuang21@vghtpe.gov.tw Ching-Ching Sheng ED ORCID: 0009-0004-9324-0448 Shuan-Yi Su ORCID: 0009-0009-6729-6989 Hsin-Yi Huang Hsiao-Hui Chiu EP T ORCID: 0000-0001-5073-3323 ORCID: 0000-0002-4889-3982 This is an open access article under the CC BY-NC-ND license A C C (http://creativecommons.org/licenses/by-nc-nd/4.0/). 2 Abstract Background: Vitamin D plays a role in immune regulation and may influence COVID-19 outcomes. This study examined the association between serum vitamin D levels with COVID-19 infection and mortality in symptomatic patients in Taiwan. ED Methods: This retrospective cohort study included symptomatic patients who underwent COVID-19 real-time polymerase chain reaction (RT-PCR) assay between 2020 and 2023. Serum 25-hydroxyvitamin D (25(OH)D) levels were categorized as deficient (<20 ng/mL), insufficient (20–30 ng/mL), or sufficient (≥30 ng/mL). Logistic regression models were used to evaluate the EP T impact of vitamin D levels on COVID-19 infection and mortality, adjusting for potential confounders including age, sex, and comorbidities. Results: Among the 481 participants (mean age 58.2 years; 66.7% female), 96 (19.96%) tested positive for COVID-19. Vitamin D level was not associated with COVID-19 infection (OR=1.00, 95% CI: 0.99–1.02, p=0.687), however vitamin D deficiency significantly increased the risk of COVID-19-related mortality (OR=10.68, 95% CI: 1.18–96.45; p=0.035). The C mortality rate in patients aged 65–74 years was higher compared to those aged 19–44 years (OR=12.91, 95% CI: 1.29–128.83; p=0.029). A C Conclusions: Vitamin D levels were not associated with susceptibility to COVID-19 infection. However, vitamin D deficiency, particularly in older patients, was associated with an increased risk of mortality among those diagnosed with COVID-19. These findings support the role of vitamin D in reducing COVID-19 mortality, and emphasize the importance of maintaining sufficient levels in high-risk populations. Keywords: COVID-19 infection;..
DOI record: { "DOI": "10.1097/jcma.0000000000001294", "ISSN": [ "1726-4901" ], "URL": "http://dx.doi.org/10.1097/JCMA.0000000000001294", "abstract": "<jats:sec>\n <jats:title>Background:</jats:title>\n <jats:p>Vitamin D plays a role in immune regulation and may influence COVID-19 outcomes. This study examined the association between serum vitamin D levels with COVID-19 infection and mortality in symptomatic patients in Taiwan.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Methods:</jats:title>\n <jats:p>This retrospective cohort study included symptomatic patients who underwent COVID-19 real-time polymerase chain reaction (RT-PCR) assay between 2020 and 2023. Serum 25-hydroxyvitamin D (25(OH)D) levels were categorized as deficient (&lt;20 ng/mL), insufficient (20–30 ng/mL), or sufficient (≥30 ng/mL). Logistic regression models were used to evaluate the impact of vitamin D levels on COVID-19 infection and mortality, adjusting for potential confounders including age, sex, and comorbidities.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Results:</jats:title>\n <jats:p>Among the 481 participants (mean age 58.2 years; 66.7% female), 96 (19.96%) tested positive for COVID-19. Vitamin D level was not associated with COVID-19 infection (OR=1.00, 95% CI: 0.99–1.02, <jats:italic toggle=\"yes\">p</jats:italic>=0.687), however vitamin D deficiency significantly increased the risk of COVID-19-related mortality (OR=10.68, 95% CI: 1.18–96.45; <jats:italic toggle=\"yes\">p</jats:italic>=0.035). The mortality rate in patients aged 65–74 years was higher compared to those aged 19–44 years (OR=12.91, 95% CI: 1.29–128.83; <jats:italic toggle=\"yes\">p</jats:italic>=0.029).</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Conclusions:</jats:title>\n <jats:p>Vitamin D levels were not associated with susceptibility to COVID-19 infection. However, vitamin D deficiency, particularly in older patients, was associated with an increased risk of mortality among those diagnosed with COVID-19. These findings support the role of vitamin D in reducing COVID-19 mortality, and emphasize the importance of maintaining sufficient levels in high-risk populations.</jats:p>\n </jats:sec>", "author": [ { "affiliation": [ { "name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC" }, { "name": "Department of Nursing, Chang Jung Christian University, Tainan, Taiwan, ROC" } ], "family": "Sheng", "given": "Ching-Ching", "sequence": "first" }, { "affiliation": [ { "name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC" } ], "family": "Su", "given": "Shuan-Yi", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC" } ], "family": "Liang", "given": "Ying", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC" } ], "family": "Cheng", "given": "Hui-Chuan", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Information Management, Taipei Veterans General Hospital, Taipei, Taiwan, ROC" } ], "family": "Huang", "given": "Hsin-Yi", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan, ROC" }, { "name": "Department of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan, ROC" }, { "name": "School of Nursing, National Defense Medical Center, Taipei, Taiwan, ROC" } ], "family": "Chiu", "given": "Hsiao-Hui", "sequence": "additional" } ], "container-title": "Journal of the Chinese Medical Association", "content-domain": { "crossmark-restriction": true, "domain": [ "lww.com", "ovid.com" ] }, "created": { "date-parts": [ [ 2025, 9, 12 ] ], "date-time": "2025-09-12T11:01:19Z", "timestamp": 1757674879000 }, "deposited": { "date-parts": [ [ 2025, 9, 12 ] ], "date-time": "2025-09-12T11:01:20Z", "timestamp": 1757674880000 }, "indexed": { "date-parts": [ [ 2025, 9, 12 ] ], "date-time": "2025-09-12T15:44:09Z", "timestamp": 1757691849531, "version": "3.44.0" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2025, 9, 12 ] ] }, "language": "en", "link": [ { "URL": "https://journals.lww.com/10.1097/JCMA.0000000000001294", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "276", "original-title": [], "prefix": "10.1097", "published": { "date-parts": [ [ 2025, 9, 12 ] ] }, "published-online": { "date-parts": [ [ 2025, 9, 12 ] ] }, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "reference-count": 0, "references-count": 0, "relation": {}, "resource": { "primary": { "URL": "https://journals.lww.com/10.1097/JCMA.0000000000001294" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Association between vitamin D and COVID-19 infection and mortality in Taiwanese patients", "type": "journal-article", "update-policy": "https://doi.org/10.1097/lww.0000000000001000" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit